Daria Mochly-Rosen is a Professor of Chemical and Systems Biology at the Stanford University School of Medicine, where she also holds the George D. Smith Chair for Translational Medicine. [1] She is in addition the founder of Mitoconix Bio, a startup company whose goal is to produce drugs that treat Huntington's disease and other neurodegenerative illnesses. [2] [3] [4]
References
- ^ "Daria Mochly-Rosen". Stanford University. Retrieved 2018-08-12.
- ^ "Neurological therapy co Mitoconix Bio raises $20m". Globes. Retrieved 2017-06-27.
- ^ "California Life Sciences Association (CLSA) Adds Leaders from City of Hope, Stanford to Board of Directors". Retrieved 2017-02-13.[ permanent dead link]
- ^ Danney, Micah (2017-07-05). "Israeli startup takes aim at Huntington's disease". The Times of Israel. Retrieved 2018-08-12.
External links
- Daria Mochly-Rosen publications indexed by Google Scholar
| International | |
|---|---|
| National | |
| Academics | |
 | This article about a biologist is a stub. You can help Wikipedia by expanding it. |